Clinical Trials in Psoriasis
|
|
- Rudolph Maxwell
- 6 years ago
- Views:
Transcription
1 Clinical Trials in Psoriasis A positive approach to psoriasis and psoriatic arthritis
2 Introduction When you go to the pharmacy to collect the treatment your doctor has prescribed, have you ever wondered how that treatment has been developed and how its efficacy has been proven? This booklet will take you on a journey on the life of a medicinal product and will also explain in detail the concept of clinical trials so that you are better informed on your rights and can make an informed decision when asked to participate. The process of drug development is long. Did you know that most of the medicines that you buy from your pharmacist have undergone a year testing period before they could be prescribed and sold! This may help explain why some treatments are so expensive! When a new treatment is discovered, it is usually in the form of a chemical molecule. This molecule will initially be tested using standard laboratory tests for its effects on say inflammation or skin differentiation. If the results from these initial tests are promising the process of drug development will be initiated. Drug development may involve a number of things such as the technical aspects of a chemical scale up, analytical analysis of the material and pharmaceutical development of a dosage form and formulation. Development also refers to the entire process of taking a newly discovered compound through regulatory approval and to the point of marketing. One of the most important decisions that a company makes, is which of its novel molecules it will develop into a medical treatment. Only 1 in 10,000 molecules makes it to the market! Therefore this is indeed a key decision which is made according to established criteria, specific for each company. When a chemical compound is found that meets these criteria then it is developed as a medicine. The compound will continue to be developed until events demonstrate that some of the criteria (especially that of safety and efficacy) cannot be met and that it is no longer likely or possible to achieve a medically and commercially viable medicine. As a psoriasis sufferer you may be accustomed to using creams as opposed to tablets. These creams however, go through the same rigorous process of analysis and evaluation as an oral treatment. One must understand that a drug, be it topical or oral is a medication and will therefore have undergone all the controls and tests required by the law. People that think 2
3 topically applied treatments are weak medications are wrong. Topical treatments are preferred in dermatology because these will act directly on the diseased organ:- ie the skin. The development plan The development plan refers to the development of a molecule into a medical treatment. The first phase of the development plan includes pharmacology and toxicology studies that are primarily carried out in animals. In these preliminary studies the therapeutic action is evaluated in terms of active dose, toxicity and side effects. Parallel with this, the formulation department will work on incorporating the active molecule into different types of creams and gels that will eventually be applied onto the skin. Once researchers are satisfied with the results from these initial stages will the clinical trials on humans commence. The aim of these clinical trials is to register the new treatment with the Medicines Control Agency (MCA). Therefore a number of studies will be carried out, following the different phases outlined below, in order to collect information for the submission of the new drugs dossier. Thus, this is a highly controlled process in which registration will only take place if the data is sufficient, accurate and thereby acceptable by the MCA. Indeed, clinical trials have to be rigorously planned and carried out in order to ensure the utmost amount of safety for the subject trying out the molecule and the utmost amount of accuracy in testing the effects of the new treatment. Planning a clinical trial? There are certain parties involved in the planning of a clinical trial. Usually a pharmaceutical company will have a new drug to register and will therefore have a corresponding development plan to carry out. This development plan will include numerous clinical trials in order to prove the efficacy and safety of this new treatment on human subjects. Specialists from the company will be responsible for the design of the trials and for choosing an investigator (a dermatologist) for carrying out each trial. The design of these trials will correspond to the objectives for each particular study. These objectives in turn will correspond to the major and minor questions that the study is designed to answer. In all types of studies the objective should be stated as specifically as possible in the protocol. The protocol is the bible of clinical trials since it contains an accurate and complete 3
4 description of the methodology of the trial, evaluations to be made during the trial, general information on the personnel involved in the trial and indeed all the reglementary sections. > Methodology of the trial The protocol will contain an accurate and complete description of the study methodology. This will include : Name and description of the new treatment. Summary of findings of other studies already carried out. When and how the patient should apply the treatment. Description of the population to be studied. An accurate description of trial design including the measures taken to avoid bias. The expected duration of participation. A description of the stopping rules. > Evaluations Methods, timing and specification of the efficacy and safety parameters. Procedure for eliciting reports and reporting any side effects and inter current illnesses. Description of the statistical procedures to be used in analysing the data obtained during the trial. > General information Name and address of the pharmaceutical company who is carrying out the trial. Name and address of the investigator carrying out the trial. Name, address and telephone number of everybody involved in the conception, design and carrying out of the clinical trial. > Reglementary section Financing and insurance of the study. Data handling and record keeping procedures. Description of the ethical considerations relating to the trial. Description of quality control and quality assurance to be adopted during the trial. 4
5 This protocol will then be submitted to the local ethics committee an independent group of people, appointed by the local health authority, which includes doctors, nurses, medical staff, lawyers and members of the public. They will decide whether the trial is ethical. In particular they check that: The researchers are qualified to carry out the trial. The protocol is suitable for the needs of the trial. The probable benefits of a new treatment outweigh the side effects. There is enough information for participants. The way in which people will be recruited is correct. The local health facilities can support the trial. Once the protocol has been approved by the ethics committee, the study can commence. Clinical trials explained The purpose and objectives of a study are usually related to some degree with the phase of clinical testing the study drug is in. There are four phases of clinical testing: Phase one: This is the initial administration in healthy human subjects. Healthy subjects are chosen for this phase since it is easier to control an unexpected adverse reaction. The main objective at this stage is to verify the dosage of treatment which is well tolerated. Hence these studies require extreme precaution and care and will be closely monitored by both doctors and research personnel. Safety evaluations are the primary and almost always the sole objectives. The doses administered are chosen after careful analysis of the results obtained in animals. Usually very small doses are used, these are then increased accordingly. Phase two: These are the studies designed to evaluate efficacy in selected populations of patients for whom the drug is intended. These studies are rigorous and well controlled and are carried out in a small population of patients with similar disease characteristics. By the time the treatment reaches phase two, researchers will know quite a lot about it since only those treatments which look 5
6 promising in phase one will progress to phase two. Phase one will have shown what the major side effects are and whether they are acceptable in relation to any potential benefit. Phase three: These studies are conducted in patient populations for which the drug is eventually intended. These studies generate additional data on both safety and efficacy on much larger and more heterogenous groups of patients than phase two studies. Often the studies entail a comparison between the new product and a treatment already available in the shops. These studies provide much of the information that is needed for the package insert and labelling of the drug. If you are asked to take part in a phase two or phase three study there are a number of terms which you may hear: Most of these trials will be randomised. This means that a computer will randomly allocate patients to one or other of the treatment groups in the trial. This is done so that each group has a non biased mix of patients of different ages and sex. If it were left to the researchers to decide who should get which treatment they might be influenced by what they know about their patients. Consciously or unconsciously they might put patients who were more or less likely to respond to a new treatment into that group. This would introduce bias, making the results unreliable. Randomised trials are by definition, controlled. A control is something with which to compare the treatment being tested. Usually the control will be the standard treatment or a placebo (dummy treatment). Without a control it is impossible to measure how much would have happened by chance or with the standard treatment. If you take part in a trial of a new treatment, you may not be told which treatment group you are in. This is called a blind trial. The medicine that all the patients are given will look the same whether it is the new treatment, standard treatment, or placebo. Some trials are double blind which means that neither you nor the doctor treating you knows which treatment you are getting. Your doctor opens a specially coded treatment pack and only the trial organisers know which particular drug it contains. Making a trial blind or double blind is again aimed at reducing bias. If you knew which treatment you were getting it might influence how you felt. For example, knowing you were taking a 6
7 new treatment might make you feel more positive or more negative, and therefore influence what you report to the researchers. Similarly, if the researchers knew you were taking a new treatment for which they had high hopes, this might affect how they judged your response to it. Phase four: This phase commences after a drug has been marketed and is commercially available. These studies are used to provide additional details required to learn more about the drug s efficacy and/or safety profile. Bearing all this in mind, it is important to be aware that before any clinical study is undertaken, careful consideration is given to the question of why the study has been proposed. Reasons for performing a study are carefully evaluated from the point of view of whether the study is truly necessary to answer the questions posed. Clincal trials in psoriasis Depending on the type of trial any of the following evaluations may be carried out on lesions: Erythema (redness): The investigator will assess the extent of redness on the treated areas. Dryness: This is defined as tight sensations on the treated area due to the unusual dryness of the skin. The dermatologist will feel the treated area himself and will also ask you if you have experienced sensations of this sort during the treatment period. Desquamation: desquamation is the abnormal shedding or peeling of the skin. The dermatologist will evaluate this parameter by looking closely at the treated area. Burning: The dermatologist will ask you if you have experienced any prickling pain sensations at any time during the course of treatment in order to evaluate burning. Pruritus: The dermatologist will ask you if you have experienced any itching sensations in order to evaluate this parameter. 7
8 Infiltration: This is a simple evaluation in which the hardness or firmness of the tissue around the site of the lesion will be assessed. As you can appreciate, all the different visual characteristics of the lesions are investigated and examined in order to assess the efficacy and safety features of the new treatment. In addition to these visual factors some clinical trials also include questionnaires about the quality of life and psychological factors. These are dealt with in the following chapter. Quality of life questionnaires? Over the last few years, researchers have developed detailed tests and questionnaires which allow them to measure the quality of life. These allow them not only to look at the effect of a new treatment on your psoriasis but also at its much wider effects on your life as a whole, and to compare these effects with those of other forms of treatment. Some of the questions you are asked during a trial may seem rather unnecessary and quite unrelated to your treatment. For example you may be asked questions such as: Over the last few weeks, how much has your skin influenced the clothes you wear? Over the last few weeks, how embarrassed or self conscious have you been because of your skin? Over the last few weeks, has your skin prevented you from working or studying? There is a good reason why you are asked such questions. The aim of any medical treatment isn t just to help you get well again. It is also geared to improving your day to day living i.e. your quality of life. Who is in charge of the clinical trial? The dermatologist who asks you to take part in a clinical trial may not be the person who designed and set up the trial. However he/she should have been fully informed about the study before agreeing to become involved and should have all the information you need. 8
9 Who can participate in clinical trials? This depends entirely on the type of clinical trial being carried out. Each trial has certain criteria which people must adhere to in order to participate. Since clinical trials investigate the effects of new treatments, it is important not to confuse these effects with that of other treatments. Therefore, one of the most common criterion is that if you wish to participate you might have to stop your current treatment for a specified period of time. Therefore depending on your own personal characteristics, you might have a clinical trial for which you are eligible but then again there might be another trial for which you are not. How can I find out more about clinical trials? The saying goes, where there is a will there is a way. This is also true for clinical trials participation is easy if you want to participate. Your dermatologist is probably the best source of information since he/she will be most certainly implicated in clinical trials of some sort. Risks and benefits? There are both risks and benefits to consider when participating in a clinical trial. When you take part in a trial you will be monitored carefully during and after the study. You will have regular evaluations and will sometimes be asked questions about how you are feeling in general. This might mean that you will go to the hospital more regularly than usual, so you should bear this in mind when agreeing to participate. Taking part in a clinical trial does not guarantee you better treatment, nor will you automatically get the treatment being tested. However your psoriasis will be closely monitored by a dermatologist during the clinical trial and therefore any changes, for better or for worse will be quickly picked up and acted upon. No one should ever include you in a clinical trial without asking you. Any doctor, nurse or other researcher should always ask your permission and, if you do not give your consent, they cannot enter you into the trial. 9
10 You will however, be helping to improve our understanding of psoriasis and the best way to treat it. This does not mean that you are obliged to take part. You should only agree to help with a trial if you are entirely happy with what you are being asked to do. It is important to be aware that you can pull out at any time if you change your mind. By reading and understanding more about clinical trials now, with time to think about all the issues, we hope you will feel happier and more confident in your decision, whether or not you agree to take part. To help you decide whether you want to take part, the researchers should tell you all about the study what it is trying to find out, how you will be treated and what you will have to do. Various guidelines have been drawn up for the researchers about the sort of information that people need in order to decide whether to take part in a clinical trial. But there is a lot of debate about how much people really want to know and, of course in practice this varies from person to person. The important thing is that you are satisfied you have enough information to make an informed decision. You should feel free to ask any questions which you believe are important in helping you to reach a decision. You should also feel satisfied that you have been given enough time to think about the trial and what it will mean to you before you decide. The person who suggests that you take part in the trial should first discuss it with you and answer your immediate questions. He/she will not be able to give you a copy of the protocol since this is a scientific document containing confidential information. However, he or she should give you a leaflet or fact sheet about the trial which you can take away and read at your leisure if you wish. If you wish to take part in the trial, you will be asked to give your written consent. However, remember that even after you have given your consent you are free to withdraw at any time. It will not affect your overall care and your doctor will not hold it against you. 10
11 Questions to ask before taking part What is the point of the trial and how will it help people? You should feel satisfied that the trial is worthwhile and that it is asking a useful question. How long will the study last? This very much depends on the type of the trial but could be anything from a couple of days to a number of months. Therefore if you have a holiday planned bang in the middle of a clinical trial it would be advisable not to participate! Can I withdraw at any time? The answer here must be YES Here is a selection of practical questions you may want to ask, to which there are no right or wrong answers. You just need to be sure that YOU are happy with the demands which the trial will make on you. How much of my time will be needed? Will I need to take time off work? Does the research budget cover the cost of my fares to and from the trial centre? What are the possible side effects of the treatment? Who can I contact if I have a problem? Will someone be available 24 hours a day? Always consult your doctor or healthcare provider. This material was produced by PAPAA. Please be aware that treatments and research is ongoing. For the latest and up to date information or any amendments to this material please contact us or visit our website. First published 2008 PAPAA Reviewed and revised May
12 The Charity for People with psoriasis and psoriatic arthritis PAPAA, the single identity of the Psoriatic Arthropathy Alliance and the Psoriasis Support Trust. The organisation is independently funded and is a principal source of information and educational material for people with psoriasis and psoriatic arthritis in the UK. PAPAA supports both patients and professionals by providing material that can be trusted (evidence based), which has been approved and contains no bias or agendas. PAPAA provides positive advice that enables people to be involved as they move through their healthcare journey in an informed way, which is appropriate for their needs and any changing circumstances. Contact: PAPAA PO Box 111 St Albans Herts AL2 3JQ Tel: Fax: info@papaa.org ISBN CT/05/10 Psoriasis and Psoriatic Arthritis Alliance is a company limited by guarantee registered in England and Wales No Registered Charity No Registered office: Acre House, William Road, London, NW1 3ER
How Clinical Trials Work
A Guide to: How Clinical Trials Work Clinical trials are rigorously controlled tests designed to examine the safety and / or effectiveness of medicines, devices, treatments, or preventive measures in humans.
More informationPlanning for a time when you cannot make decisions for yourself
Planning for a time when you cannot make decisions for yourself An information leaflet for members of the public Version: October 2013 Introduction The Mental Capacity Act 2005 allows you to plan ahead
More informationNational NHS patient survey programme Survey of people who use community mental health services 2014
National NHS patient survey programme Survey of people who use community mental health services The Care Quality Commission The Care Quality Commission (CQC) is the independent regulator of health and
More informationHow to get involved in Cystic Fibrosis Research
How to get involved in Cystic Fibrosis Research Information for patients and the public www.uhsm.nhs.uk/cysticfibrosis www.facebook.com/macfc.uhsm CONTENTS 4 GENERAL INFORMATION 4 Who is this booklet
More informationProfessional Development: proposals for assuring the continuing fitness to practise of osteopaths. draft Peer Discussion Review Guidelines
5 Continuing Professional Development: proposals for assuring the continuing fitness to practise of osteopaths draft Peer Discussion Review Guidelines February January 2015 2 draft Peer Discussion Review
More informationPATIENT STUDY INFORMATION LEAFLET
PATIENT STUDY INFORMATION LEAFLET BOOKLET 1 You are invited to take part in this research study. Before you decide, it is important for you to understand why the research is being done and what it will
More informationA guide to prostate cancer clinical trials
1 A guide to prostate cancer clinical trials In this fact sheet: What is a clinical trial? Why are trials done? What are trials looking into at the moment? What happens in a clinical trial? Should I take
More informationTCIs are only available on prescription and are usually started by a dermatology specialist.
(TCIs) What are topical calcineurin inhibitors? Topical calcineurin inhibitors are treatments that alter the immune system and have been developed for controlling eczema. There are two types available:
More informationClinical Trials: Improving the Care of People Living With Cancer
CLINICAL TRIALS Clinical Trials: Improving the Care of People Living With Cancer Presented by Mary McCabe, RN, MA Memorial Sloan-Kettering Cancer Center Carolyn Messner, DSW CancerCare Learn about: Stages
More informationVANISH Vasopressin vs Noradrenaline as Initial therapy in Septic shock
Investigator: Maurizio Cecconi Patient Information Sheet You are being invited to take part in a research study. Before you decide it is important for you to understand why the research is being done and
More informationSUPPORTED LODGINGS. Providing a bridge to independent living for young people. Supported Lodgings
SUPPORTED LODGINGS Providing a bridge to independent living for young people Supported Lodgings A message from the supported lodgings team at Hull City Council Thank you for your interest. In our area
More informationGetting the best from the medicines you buy
Getting the best from the medicines you buy You can buy many medicines without needing to see your doctor. These are often called over-the-counter medicines. They are safe and effective as long as you
More informationIf you or one of your relatives has Parkinson s, you may want to know
Information and support Does Parkinson s run in families? If you or one of your relatives has Parkinson s, you may want to know if the condition can be passed down through families. This information sheet
More informationAdvance Statements. What is an Advance Statement? Information Line: Website: compassionindying.org.uk
Information Line: 0800 999 2434 Website: compassionindying.org.uk This factsheet explains what an Advance Statement is and how to make one. It is for people living in England and Wales. If you live in
More informationTaking Part in Cancer Treatment Research Studies
Taking Part in Cancer Treatment Research Studies U.S. Department of Health & Human Services National Institutes of Health Taking Part in Cancer Treatment Research Studies If you have cancer, you may want
More informationMaking things better in mental health services. Making things better in mental health services an Easy Read guide to No decision about us without us
Making things better in mental health services an Easy Read guide to No decision about us without us Contents 4 What this guide is about 5 The mental health framework 5 How you can help with the framework
More informationOccupational therapy after stroke
Call the Stroke Helpline: 0303 3033 100 or email: info@stroke.org.uk Occupational therapy after stroke This guide explains how occupational therapy can help your recovery and rehabilitation after a stroke.
More informationA practical guide to living with and after cancer. Planning your care and support. Front cover
A practical guide to living with and after cancer Planning your care and support Front cover 1 Holistic Needs Assessment About this leaflet Being diagnosed with cancer can affect many areas of your life.
More informationLiving well today...32 Hope for tomorrow...32
managing diabetes managing managing managing managing managing managing diabetes Scientific research continually increases our knowledge of diabetes and the tools to treat it. This chapter describes what
More informationGLUTEN-FREE FOOD SCHEME. Information Pack
GLUTEN-FREE FOOD SCHEME Information Pack The Tayside Gluten-Free Food Scheme is part of the Scottish Gluten-Free Food Service. There are variations from the Scottish Service and more information can be
More informationAbout this consent form
Protocol Title: Development of the smoking cessation app Smiling instead of Smoking Principal Investigator: Bettina B. Hoeppner, Ph.D. Site Principal Investigator: n/a Description of Subject Population:
More informationAbout this consent form. Why is this research study being done? Partners HealthCare System Research Consent Form
Protocol Title: Gene Sequence Variants in Fibroid Biology Principal Investigator: Cynthia C. Morton, Ph.D. Site Principal Investigator: Cynthia C. Morton, Ph.D. Description of About this consent form Please
More informationUsing medicines beyond licence
Using medicines beyond licence Information for patients Prepared on behalf of the Association for Palliative Medicine and the British Pain Society. November 2005 To be reviewed in November 2008. Copyright:
More informationA practical guide to living with and after cancer. Helping you take an active role in your cancer care
A practical guide to living with and after cancer Helping you take an active role in your cancer care About this leaflet About this leaflet 2 This leaflet is about how you can take an active role in your
More informationYour guide to private dentistry. Questions to ask
Your guide to private dentistry Questions to ask When you are choosing private treatment it pays to shop around and to ask the right questions. Unlike National Health Service (NHS) care, where there are
More informationMaking medical decisions
Making medical decisions Summary information for family and friends Making medical decisions when someone is in a vegetative or minimally conscious state This information sheet is for the family and close
More informationJUST DIAGNOSED WITH DIABETES?
JUST DIAGNOSED WITH DIABETES? Being told that you have diabetes can be a real shock. And learning to live with it can be a challenge. You might be going through all sorts of emotions. It s perfectly normal
More informationHREC/17/RCHM/334 RCH HREC 37278A. ANZ CLARITY Establishment of a National Juvenile Idiopathic Arthritis Biobank.
HREC Project Number: Research Project Title: Principal Researchers: HREC/17/RCHM/334 RCH HREC 37278A ANZ CLARITY Establishment of a National Juvenile Idiopathic Arthritis Biobank. Associate Professor Justine
More informationAdult Patient Information and Consent Form
The ROAM Trial Radiation versus Observation following surgical resection of Atypical Meningioma: a randomised controlled trial
More informationPatient information leaflet. A study of low dose theophylline in Chronic Obstructive Pulmonary Disease (COPD)
Patient information leaflet A study of low dose theophylline in Chronic Obstructive Pulmonary Disease (COPD) Theophylline With Inhaled CorticoSteroids (TWICS) study. We would like to invite you to take
More informationConsent to research. A draft for consultation
Consent to research A draft for consultation 1 Consent to research About the guidance Our guidance Consent: patients and doctors making decisions together (2008) 1 sets out the principles of good practice
More informationHow is the introduction of a new medicine regulated in the UK?
Information provided to Duchenne muscular dystrophy patient organisations regarding Raxone (idebenone) and the Early Access to Medicines Scheme in the UK (EAMS 46555/0001) A medicine called Raxone, which
More informationMen s Sheds Health and Well-being Survey
Men s Sheds Health and Well-being Survey When I feel like I need refreshed and lifted up, I know that twice a week my shed will be there waiting. The growth of interest in men s sheds and the establishment
More informationNational Inspection of services that support looked after children and care leavers
National Inspection of services that support looked after children and care leavers Introduction Children and young people that are looked after and those leaving care need the best support possible. Support
More informationWhat happens if I cannot make decisions about my care and treatment?
Information Line: 0800 999 2434 Website: compassionindying.org.uk What happens if I cannot make decisions about my care and treatment? This factsheet explains how decisions are made about your care or
More informationMINISTRY OF HEALTH MANATU HAUORA UNDER
MINISTRY OF HEALTH MANATU HAUORA UNDER MINISTRY OF HEALTH MANATu HAUORA Published in June 1999 by the Ministry of Health, Manatū Hauora PO Box 5013, Wellington ISBN 0-478-23548-8 (Booklet) ISBN 0-478-23549-6
More informationHearing Loss Advice. Contents. Signs of hearing loss. Are any of these situations familiar? Signs of hearing loss All about hearing aids Contact
Hearing Loss Advice Many people become hard of hearing as they get older due to the loss of specialised cells that are needed for the cochlea to work properly. The cochlea is the innermost part of your
More informationThe New Mental Health Act A Guide to Named Persons
The New Mental Health Act A Guide to Named Persons The New Mental Health Act A Guide to Named Persons Scottish Executive, Edinburgh 2004 Crown copyright 2004 ISBN: 0-7559-4345-7 Scottish Executive St Andrew
More informationPsoriasis and the Heart
Psoriasis and the Heart A positive approach to psoriasis and psoriatic arthritis What is psoriasis? Psoriasis (Ps) is a long-term (chronic) scaling disease of the skin, which affects 2% 3% of the UK population.
More informationUse of unlicensed medicines and off-label uses
Use of unlicensed medicines and off-label uses 25 Promoting hope and wellbeing together What is this leaflet about? Your doctor or pharmacist has given you this leaflet because a medicine that you have
More informationPatient Information Sheet
Research Trial of Treatments for Patients with Bony Metastatic Cancer of the Prostate. - TRAPEZE Patient Information Sheet Your doctor has explained to you that your prostate cancer is no longer responding
More informationGlobal Pulse Oximetry Project
3.3 Introduction of new health technologies: lessons learned Over the past twenty years there have been a number of comprehensive public health projects which illustrate important lessons regarding the
More informationClinical Trials: Questions and Answers
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Clinical Trials: Questions
More information5: Family, children and friends
5: Family, children and friends This section will help you to manage difficult conversations as people close to you adjust to your diagnosis of MND. The following information is an extracted section from
More informationMental capacity and mental illness
Mental capacity and mental illness The Mental Capacity Act 2005 (MCA) Mental capacity is the ability to make your own decisions. If you lose mental capacity the Mental Capacity Act 2005 (MCA) protects
More informationINFORMATION BROCHURE - ALLOCATE
INFORMATION BROCHURE - ALLOCATE AustraLian Ovarian Cancer Assortment Trial Principal Investigator: Prof Michael Quinn, Royal Women s Hospital This Participant Information Sheet and Consent Form is 7 pages
More informationCONSENT FORM. The Full Study Title Should Be Placed Here. Principal Investigator: Dr. John Smith Sub-Investigator: Dr. Jane Smith
CONSENT FORM The Full Study Title Should Be Placed Here. Principal Investigator: Dr. John Smith Sub-Investigator: Dr. Jane Smith Queen Elizabeth Hospital Queen Elizabeth Hospital 60 Riverside Drive 60
More informationDay care and childminding: Guidance to the National Standards
raising standards improving lives Day care and childminding: Guidance to the National Standards Revisions to certain criteria October 2005 Reference no: 070116 Crown copyright 2005 Reference no: 070116
More informationA helping hand when you need it most
A helping hand when you need it most Priority Services Register Promise The Priority Services Register (PSR) is free to join. It helps energy companies * like us to look after customers who have extra
More informationOccupational therapy after stroke
Call the Stroke Helpline: 0303 3033 100 or email: info@stroke.org.uk Occupational therapy after stroke This guide explains how occupational therapy can help your recovery and rehabilitation after a stroke.
More informationCouples Information Leaflet
Couples Information Leaflet This project was funded by the National Institute for Health Research, Health Technology Assessment Programme (project number 13/115/82) You are due to undergo in vitro fertilisation
More informationPATIENT INFORMATION SHEET
PATIENT INFORMATION SHEET Optimal management of Rheumatoid Arthritis patients who require Biologic Therapy (ORBIT study) a randomized controlled trial comparing Rituximab and anti-tnf therapy. Invitation
More informationHelping you understand the care and support you can ask for in Wales.
Helping you understand the care and support you can ask for in Wales. Contents About this leaflet What type of support can I ask for? What type of information can I ask for? What questions can I ask my
More informationLife After Prostate Cancer Diagnosis Research Study
Life After Prostate Cancer Diagnosis Research Study If you are looking at this information sheet this means you have read the covering letter and therefore have had a diagnosis of prostate cancer. If you
More informationSuspected CANcer (SCAN) Pathway Information for patients
Suspected CANcer (SCAN) Pathway Information for patients page 2 Your GP has advised you may benefit from investigation via the SCAN pathway. The SCAN pathway is part of a national programme called ACE
More informationCost-Utility Analysis (CUA) Explained
Pharmaceutical Management Agency Cost-Utility Analysis (CUA) Explained Cost-Utility Analysis (CUA) at PHARMAC Questions and Answers go to page 9 >> This document explains the process that PHARMAC generally
More informationI M REGISTERED. Promoting your status as a registered health professional. A guide for osteopaths
I M REGISTERED Promoting your status as a registered health professional A guide for osteopaths 2 Why is it important for me to raise awareness of my registration? Patients want to be assured that you
More informationNAS NATIONAL AUDIT OF SCHIZOPHRENIA. Second National Audit of Schizophrenia What you need to know
NAS NATIONAL AUDIT OF SCHIZOPHRENIA Second National Audit of Schizophrenia What you need to know Compiled by: Commissioned by: 2 October 2014 Email: NAS@rcpsych.ac.uk The National Audit of Schizophrenia
More informationPatient survey report Survey of people who use community mental health services 2015 South London and Maudsley NHS Foundation Trust
Patient survey report 2015 Survey of people who use community mental health services 2015 National NHS patient survey programme Survey of people who use community mental health services 2015 The Care
More informationPalliative Care Asking the questions that matter to me
Palliative Care Asking the questions that matter to me THE PALLIATIVE HUB Adult This booklet has been developed by the Palliative Care Senior Nurses Network and adapted with permission from Palliative
More informationVocabulary. Bias. Blinding. Block. Cluster sample
Bias Blinding Block Census Cluster sample Confounding Control group Convenience sample Designs Experiment Experimental units Factor Level Any systematic failure of a sampling method to represent its population
More informationInformation provided to Duchenne muscular dystrophy patient organisations regarding Raxone
Information provided to Duchenne muscular dystrophy patient organisations regarding Raxone (idebenone) and the Early Access to Medicines Scheme in the UK (EAMS 46555/0001) April 26 th 2018 Raxone tablets
More informationHow is primary breast cancer treated? This booklet is for anyone who has primary breast cancer and wants to know more about how it is treated.
How is primary breast cancer treated? This booklet is for anyone who has primary breast cancer and wants to know more about how it is treated. How is primary breast cancer treated? Part 1 the treatment
More informationPreventing obesity and staying a healthy weight
Understanding NICE guidance Information for the public Preventing obesity and staying a healthy weight NICE advises the NHS on caring for people with specific conditions or diseases. It also advises the
More informationWelcome to Lead Scotland Specialists in Linking Education and Disability
Welcome to Lead Scotland Specialists in Linking Education and Disability Lead Scotland - Scottish charity no 003949. Company Ltd by Guarantee, registered in Scotland, 110186. Lead Scotland, Linking Education
More informationBRAIN DEATH. Frequently Asked Questions 04for the General Public
BRAIN DEATH Frequently Asked Questions 04for the General Public Neurocritical Care Society BRAIN DEATH FAQ s FOR THE GENERAL PUBLIC NEUROCRITICAL CARE SOCIETY 1. Q: Why was this FAQ created? A: Several
More informationADHD clinic for adults Feedback on services for attention deficit hyperactivity disorder
ADHD clinic for adults Feedback on services for attention deficit hyperactivity disorder Healthwatch Islington Healthwatch Islington is an independent organisation led by volunteers from the local community.
More informationHow Ofsted regulate childcare
Information for parents about Ofsted s role in regulating childcare This section provides information about how Ofsted regulates childcare providers. It sets out how you might like to use the information
More informationDIRECTIONS FOR USING THE MENTAL HEALTH ADVANCE DIRECTIVE POWER OF ATTORNEY FORM
(800) 692-7443 (Voice) (877) 375-7139 (TDD) www.disabilityrightspa.org DIRECTIONS FOR USING THE MENTAL HEALTH ADVANCE DIRECTIVE POWER OF ATTORNEY FORM 1. Read each section very carefully. 2. You will be
More informationGCSE PSYCHOLOGY UNIT 2 FURTHER RESEARCH METHODS
GCSE PSYCHOLOGY UNIT 2 FURTHER RESEARCH METHODS GCSE PSYCHOLOGY UNIT 2 SURVEYS SURVEYS SURVEY = is a method used for collecting information from a large number of people by asking them questions, either
More informationLUNG CANCER CLINICAL TRIALS
UNDERSTANDING SERIES LUNG CANCER CLINICAL TRIALS 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT THE BASICS ABOUT CLINICAL TRIALS WITH MORE INFORMATION YOU CAN MAKE BETTER CHOICES. The decision
More informationPatient information brochure
Clinical Development and Medical Affairs Patient information brochure 1. European Medicines Agency. Nilotinib Summary of Product Characteristics. March 2013. Available from: www.ema.europa.eu/ema/index.
More informationCopyright 1980 Alcoholics Anonymous World Services, Inc. Mail address: Box 459 Grand Central Station New York, NY
ALCOHOLICS ANONYMOUS is a fellowship of men and women who share their experience, strength and hope with each other that they may solve their common problem and help others to recover from alcoholism.
More informationPain Notebook NAME PHONE. Three Hole Punch Here Three Hole Punch Here. Global Pain Initiative 2018 Ver 1.0
Pain Notebook Three Hole Punch Here Three Hole Punch Here NAME EMAIL PHONE Global Pain Initiative 2018 Ver 1.0 What is pain? Pain is a bad sensation that tells you something is wrong. Pain falls into two
More informationPATIENT STUDY INFORMATION LEAFLET
PATIENT STUDY INFORMATION LEAFLET BOOKLET 1 You are invited to take part in this research study. Before you decide, it is important for you to understand why the research is being done and what it will
More informationPreparing for an Oral Hearing: Taxi, Limousine or other PDV Applications
Reference Sheet 12 Preparing for an Oral Hearing: Taxi, Limousine or other PDV Applications This Reference Sheet will help you prepare for an oral hearing before the Passenger Transportation Board. You
More informationNewcomer Asks. This is A.A. General Service Conference-approved literature.
A Newcomer Asks This is A.A. General Service Conference-approved literature. Alcoholics Anonymous is a fellowship of men and women who share their experience, strength and hope with each other that they
More informationThis section will help you to identify and manage some of the more difficult emotional responses you may feel after diagnosis.
4: Emotional impact This section will help you to identify and manage some of the more difficult emotional responses you may feel after diagnosis. The following information is an extracted section from
More informationUNDERSTANDING CLINICAL TRIALS FOR CANCER FIND OUT MORE
UNDERSTANDING CLINICAL TRIALS FOR CANCER FIND OUT MORE We know that people affected by cancer have a lot of questions. We can help you find reliable, clear and easy to understand answers. In this leaflet
More informationAre you looking after someone?
Are you looking after someone? PARK Essential information for carers Carers Week is an annual campaign to celebrate and recognise the 6.5 million people in the UK who care (unpaid) for family or friends
More informationSleep, Wake and Light therapy for depression
Sleep, Wake and Light therapy for depression We would like to invite you to take part in a study called Sleep, Wake and Light Therapy for treating depression You do not have to take part if you do not
More informationState of Connecticut Department of Education Division of Teaching and Learning Programs and Services Bureau of Special Education
State of Connecticut Department of Education Division of Teaching and Learning Programs and Services Bureau of Special Education Introduction Steps to Protect a Child s Right to Special Education: Procedural
More informationHOW TO SPOT A FOOT ATTACK PREVENTING SERIOUS FOOT PROBLEMS
HOW TO SPOT A FOOT ATTACK PREVENTING SERIOUS FOOT PROBLEMS Your foot check has shown that there is a high risk that you could develop serious foot problems 2 YOUR FEET MATTER If you ve been given this
More informationSmile. Your dental team have check ups too
Smile Your dental team have check ups too Whether you re visiting for a routine check up, a quick clean or for more involved treatment, the dental professional treating you (and their services) must meet
More informationUnproven treatments and motor neurone disease
C Unproven treatments and motor neurone disease This information sheet presents the facts about alternative or unproven treatments. It aims to provide people with the information they need in order to
More informationDeciding whether a person has the capacity to make a decision the Mental Capacity Act 2005
Deciding whether a person has the capacity to make a decision the Mental Capacity Act 2005 April 2015 Deciding whether a person has the capacity to make a decision the Mental Capacity Act 2005 The RMBI,
More informationMENTAL HEALTH ADVANCE DIRECTIVE
Mental Health Association in Pennsylvania 2005 Instructions and Forms MENTAL HEALTH ADVANCE DIRECTIVES FOR PENNSYLVANIANS MENTAL HEALTH ADVANCE DIRECTIVE I,, have executed an advance directive specifying
More informationConsultation Summary Birmingham Homelessness Prevention Strategy 2017+
Consultation Summary Birmingham Homelessness Prevention Strategy 2017+ 24 August - 5 October 2017 This leaflet is easier to read What are we trying to achieve? (This part will help you answer Questions
More informationSelf-directed support
Self-directed support The Mental Capacity Act 2005 This gives a brief introduction to the Mental Capacity Act 2005. The Mental Capacity Act contains a lot of information and this gives a very general overview
More informationWelcome to the Community Children and Young People s Service. Information you will find useful during your contact with the service
Welcome to the Community Children and Young People s Service Information you will find useful during your contact with the service 1 Contents Page Support in a crisis 3 About the service 4 Appointments..
More informationPain CONCERN. Medicines for long-term pain. Opioids
Pain CONCERN Medicines for long-term pain Opioids Opioids are a group of medicines that come from the extract of poppy seeds or other medicines that work in the same way. Types of opioid The first opioids
More informationLidocaine Hydrochloride BP 2% w/v in Lutrol F127 24% w/v Sterile Gel. Information for patients Pharmacy
Lidocaine Hydrochloride BP 2% w/v in Lutrol F127 24% w/v Sterile Gel Information for patients Pharmacy This leaflet contains important information about your medicine; please read it carefully. If you
More informationThe post-mortem examination for a baby or child
Contents What is a post-mortem? 3 Why are post-mortems carried out? 3 How are post-mortems carried out? 4 What happens after the post-mortem? 6 Getting the results of a post-mortem 8 Giving consent for
More informationNon-epileptic attacks
Non-epileptic attacks A short guide for patients and families Information for patients Neurology Psychotherapy Service What are non-epileptic attacks? Non-epileptic attacks are episodes in which people
More informationSeldom Heard Voices Visual & Hearing Sensory Loss Prepared by: South Lincs Blind Society
Seldom Heard Voices Visual & Hearing Sensory Loss Prepared by: South Lincs Blind Society Healthwatch Lincolnshire Supporting Seldom Heard Voices Healthwatch Lincolnshire was formed under the Health and
More informationAnkle arthroscopy. If you have any further questions, please speak to a doctor or nurse caring for you
Ankle arthroscopy This leaflet aims to answer your questions about having an ankle arthroscopy. It explains the benefits, risks and alternatives, as well as what you can expect when you come to hospital.
More informationPeer Mentoring Guide for Student Mentees
Peer Mentoring Guide for Student Mentees 2 Contents Welcome and Introduction 3 Frequently Asked Questions 4-5 What Students Say... 6 Guidelines for Mentees 7 Data Protection Both mentors and mentees must
More informationCLINICAL EVIDENCE MADE EASY
CLINICAL EVIDENCE MADE EASY M HARRIS, G TAYLOR & D JACKSON THE BASICS OF EVIDENCE-BASED MEDICINE CLINICAL EVIDENCE MADE EASY CLINICAL EVIDENCE MADE EASY M. Harris General Practitioner and Visiting Senior
More informationCaring for someone who has self-harmed or had suicidal thoughts. A family guide
Caring for someone who has self-harmed or had suicidal thoughts A family guide This booklet is aimed at the families/carers of people who have self-harmed or had suicidal thoughts. It will be provided
More informationOffice of Clinical Research. Information for Participants
Office of Clinical Research Information for Participants Research and You Welcome to one of the best health systems in the nation. It is one of the best because as well as highquality, state-of-the-art
More information